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Abstract 
A major goal in antitumor and antiviral therapy is to find active ingredients that selectively suppress the 
proliferation of tumor cells or inhibit viral replication and proliferation. In this connection, the antitumor and 
antiviral activity of natural products with proven phytochemical properties and pharmacological significance are 
actively investigated. A promising candidate are Bulgarian cranberries from high mountain plant populations, 
which are a valuable natural source of food and have proven healing properties in urinary tract infections, eye 
diseases and cardiovascular disorders, as well as prevention of hypertension and diabetes. The active 
components of Vaccinium vitis-idaea L. are polyphenols and anthocyanins which belong to classes of plant 
components with high antioxidant, antimicrobial, cytotoxic and antiproliferative activity. Cranberries contain a 
high percentage and variety of vitamins (A,  E, C,  etc.) and a number of minerals (K, Ca, Mg, P, Na). In the 
world regions where endemic measles outbreaks occur, for secondary prevention and avoidance of 
complications including blindness, WHO recommends the use of high doses of vitamin A in children under 5 
years of age. Bulgarian cranberries are a valuable source of vitamins A and C.  
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The assessement of biological activity of the individual components and fractions in the composition of the 
Bulgarian cranberries may help to identify substances with antitumor and/or antiviral activity that could 
potentially be useful in future development of new therapeutic agents. 
Keywords: Bulgarian cranberries; measles; antitumor and antiviral activity. 
1. Introduction  
Cancer is a serious problem for modern science, considering late diagnosis, inadequately effective therapy and 
prevention. Despite the combined efforts of the scientific community, the mechanisms of tumorigenesis have 
not yet been fully elucidated. The frequency of these diseases for the last decades has been steadily increasing. 
One of the main reasons for the lack of effective therapy is the molecular heterogeneity of the malignant 
process. Along with efforts to understand the complex genetic and epigenetic factors and mechanisms that 
trigger a carcinogenic process, it is also necessary to analyze the potential active substances that may delay or 
even stop the progression of carcinogenesis. 
Viral infections in humans are common, characterized by high mortality and development of complications of 
varying clinical severity requiring hospital treatment. These pathogens are responsible for neoplastic 
transformations, including the development of a number of severe diseases. Some difficult to treat and complex 
syndromes are associated with viral infections, including type 1 diabetes and hepatocellular carcinoma [1]. Due 
to the increasing number of travelling and fast urbanization there is a higer risk of rapidly expanding and 
emerging new epidemic outbreaks. The rapid spread of emerging viruses with pandemic potential is a threat to 
public health, especially in the absence of preventive vaccines and effective antiviral therapy. Examples in this 
relation, is the appearance and rapid spread of Severe acute Respiratory Syndrome (SARS), the Middle East 
Respiratory Syndrome MERS- SoV, measles, West Nile [2; 3] and the avian influenza viruses.  
The Paramyxoviridae family includes mоrbillivirus (MV, genus Morbillivirus), along with human parainfluenza 
viruses (hPIV) and mumps virus. In early childhood these pathogens are important and represent a serious 
problem for the pediatric practice. The MV remains a serious threat to children's health, despite the presence of 
an effective attenuated vaccine [4; 5]. Approximately 30% of the reported patients with measles infection have 
one or more complications and the debilitating effects are most common among children under the age of five 
years. Data for 2014 shows about 115,000 deaths in children (mostly under 5 years of age) as a result of measles 
infection. Although most newly diagnosed patients are registered in countries with limited access to vaccination, 
outbreaks still occur in some countries that have failed to maintain high levels of vaccine coverage or those with 
enhanced migratory status. Since 2004, Bulgaria has been included in the WHO Program for the elimination of 
measles and rubella (including Congenital rubella) in the European Region and is active in seroepidemiological 
surveillance. Nevertheless, in 2009-2011, after a long inter-epidemic period (7 years), one of the largest 
epidemics in the European Region breaks out – with more than 24,000 people infected (morbidity - 324%) and 
24 dead (Mortality - 0.3%, lethality - 0.1%) [6]. During the period 2011-2013, large epidemics of measles have 
also been registered in France, Ukraine, Georgia and Turkey. In the end of 2016 and the beginning of 2017, an 
epidemic of measles in Romania has been reported, affecting for several months all the regions of the country, 
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with over 4,000 affected so far, including 17 deaths, mostly children under 1 year of age. In Bulgaria, after a 
period of three years when only sporadic cases of measles occurred, in the beginning of 2017 there was a high 
jump of the people affected, with more than 200 cases in three regional cities and their adjacent areas in the 
country, namely Plovdiv, Pazardzhik and Montana. The reasons for the new epidemic outbreaks of measles are 
very complex. These include weaker vaccine immunity, naturally acquired protection and lower vaccine 
coverage levels in children in developed countries due to the unwillingness of parents to vaccinate them because 
of safety concerns for the components in the trivalent vaccine [7]. 
Currently, no specific antiviral therapy is available for treatment of measles, although drugs such as ribavirin 
and interferon α are used predominantly in severe forms of the disease. 
At present, a number of highly pathogenic viruses remain without effective immunization, and the availability of 
licensed antivirals with real use in clinical practice is insufficient. The situation is further aggravated by the 
possibility of development of drug-resistant pathogens [8]. Therefore, it is especially important to develop new 
antivirals with high efficacy, low toxicity and cost, especially in cases when there are no vaccines and standard 
therapeutical approaches. 
In oncology and clinical virology, most of the current drug agents are costly and have quite negative toxic 
effects on a number of organs and systems in the human body [9]. It is necessary to find therapeutic agents, 
which selectively and locally suppress tumor growth or viral invasion and replication without harming the body 
as a whole, in order to avoid the negative effect of the drugs used in oncology and for treatment of a number of 
viral diseases. One of the main approaches to achieving these goals is based on a study of the antitumor and 
antiviral properties of biologically active ingredients in whole extracts as well as various purified fractions of 
plants known and used for therapeutic purposes in traditional medicine. Based on such approach, an alkaloid 
inhibitor of acetylcholinesterase was found in a snowdrop (Galanthus nivalis L. var. Gracilis), which, in the 
form of the Nivalin preparation, was successfully used for the treatment of poliomyelitis, neuritis and radiculitis. 
Currently, many of the drugs used in the oncology practice have a natural origin. Achievement in this regard is 
the development of medicinal products based on paclitaxel (isolated from T. brevifolia), vincristine and 
vinblastine (derived from C. roseus) and podophyllotoxin (obtained from the roots of Podophyllum sp.) [10] 
(and others. Data obtained from highly sensitive methods and technologies indicate that some of the active 
ingredients in herbs can induce apoptosis in target cells only [11], but the mechanisms that lead to this effect are 
still too unclear. 
1.1. Current state of the research on the problem area 
There are about 3600 plant species in Bulgaria, and approximately 650 of them are considered to be healing. As 
a result of the favorable and varied climatic and soil conditions, Bulgarian plant species contain a high 
percentage of biologically active substances. They are rich in alkaloids, flavonoids, anthocyanins, glycosides, 
saponins, polysaccharides, polyphenols, tannins, and others. For some of the active substances in plants, there is 
evidence that they induce apoptosis in different types of cancer cells [12]. Epidemiological clinical trials show 
that antioxidants play a key role in the prevention of viral and cancer diseases [13]. They protect human cells 
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from oxidative damage by interacting with active oxygen radicals and metal-binding agents. 
In recent years, intensive studies of the phytochemical properties and pharmacological significance of the 
Bulgarian flora have resulted in natural products with antitumor, antioxidant, antimicrobial and 
immunomodulating effect. An example in this regard is Thaliblastine (an original Bulgarian medical product 
with antineoplastic effect obtained from Th. Aquilegifolium) and Hyperatomarin (H. annulatum) with proven 
inhibitory effect on chronic myeloid leukemia cell lines [14]. 
At this moment, antiviral therapy for infections caused by the measles virus is not available. In regions of the 
world where cases of epidemic outbreaks of measles developed, World Health Organization (WHO) and the UN 
Children's Fund recommend receiving two large doses of vitamin A, in the post-diagnosis infection in children 
under 5 years of age [15]. Vitamin A is associated with a 50% reduction in complications and mortality due to 
measles infection, although its mechanism of action remains unclear [16]. 
In this respect, the development of new therapeutics on a natural basis, effective and as innocuous as possible 
for children's health, is indispensable. Potential sources of such antiviral substances may be plants rich in 
vitamins and microelements. 
Wild berries have long been known for their antiseptic properties, antioxidant and antimicrobial activities and 
are widely used in traditional medicine in eye and cardiovascular disorders, as well as urinary tract infections 
[17]. Major representative of wild berries are cranberries (family Ericaceae, genus Vaccinium). More than 450 
species are known, mostly shrubs distributed in colder regions of the northern hemisphere. In Bulgaria are 
distributed mainly 3 types - red (Vaccinium vitis-idaea L.), black (Vaccinium myrtillus L.) and blue (Vaccinium 
uliginosum L.). Currently cranberries belong to a group of functional foods, as experimental studies have 
demonstrated their beneficial effects on different functions in the body related to reducing the risk of a number 
of pathological conditions, including socially important cancer, diabetes, osteoporosis.  
Nowadays a lot of drugs for the treatment of urogenital infections [18], atherosclerosis, including nervous 
system diseases such as Alzheimer's disease, contain cranberry as an active substance. Its fuits are rich in 
bioactive compounds such as pektin, tannins, provitamin A, vitamin B, C, PP, anthocyanins, polyphenols, Mn, 
Mg, Fe, organic acids [19] which have a proven effect against a wide range of human pathogenic bacteria and 
are beneficial to human health. Although the antimicrobial activity of the fruit has long been known and widely 
studied [20], antiviral properties have not been characterized in detail. There are separate publications reporting 
on the antiviral activity of the aqueous extracts from cranberry and black currant with respect to virus tick-borne 
encephalitis [21], of polyphenols and anthocyanins in cranberry juice against rotavirus and influenza virus [22 - 
25]. 
In recent years, the available literature data shows that there is a strong interest and active analyzes of the 
antitumor potential of various active fractions of cranberry [26; 27]. Articles exposing data from in vitro studies 
of the effects of various anthocyanins and polyphenolic substants of berries extract on human carcinoma lines, 
were found [28 - 31]. 
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Until now, data on the antiproliferative potential of extracts and purified cranberry fractions has not been 
published in Bulgaria, nor on primary cell cultures nor on immortal cell lines, and the antiviral potential data is 
exhausted by a single publication of Nikolaeva-Glomb and a team [32]. The authors analyze the antiviral 
potential of various wild berries, including blackberries and cranberries, against members of the families 
Picornaviridae - polyovirus type 1 (PV-1) and Coxaxi virus type B1 (CV-B1), Paramyxoviridae - respiratory 
syncytial virus subgroup A1 (human respiratory syncytial virus) and the family Orthomyxoviridae - influenza 
virus A (H3N2) virus, and detect the antiviral effect of total extracs on the replication of CV-B1 and influenza A 
(H3N2) viruses. 
2. Conclusion 
In this respect, the use of modern methods for detecting potential antitumor and antiviral activity of Bulgarian 
cranberries will contribute to enriching the scientific information with modern data about the biological 
activities useful for the human health of plant populations from Bulgarian flora. Cranberries refer to the category 
of medical foods with a wide range of useful active ingredients, including vitamins and microelements. A large 
number of food products and medicinal substances contain cranberries, and the conservation of their natural 
populations, as well as the building of cultural institutions in small municipalities rich in natural habitats, is a 
priority on both national and European level. 
The control of viral pathogens posing a threat to human health, such as measles, and the efforts of the scientific 
community to enrich the therapeutic resources, is also an important and priority international destination. 
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